Lui, D. T. W., Lee, C. H., Tang, V., Fong, C. H. Y., Lee, A. C. H., Chiu, J. W. Y., . . . Yau, T. (2021). Thyroid Immune-Related Adverse Events Among Cancer Patients Treated With Combination of Anti-PD1 and Anti-CTLA4 Immune-Checkpoint Inhibitors: Clinical Course and Outcomes. J Endocr Soc.
Citação norma ChicagoLui, David T W., et al. "Thyroid Immune-Related Adverse Events Among Cancer Patients Treated With Combination of Anti-PD1 and Anti-CTLA4 Immune-Checkpoint Inhibitors: Clinical Course and Outcomes." J Endocr Soc 2021.
MLA CitationLui, David T W., et al. "Thyroid Immune-Related Adverse Events Among Cancer Patients Treated With Combination of Anti-PD1 and Anti-CTLA4 Immune-Checkpoint Inhibitors: Clinical Course and Outcomes." J Endocr Soc 2021.